Stock Research for APRI


Featured Broker: Ally Invest

Get the due diligence for another stock.


APRI Stock Chart & Research Data

The APRI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APRI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


APRI Due diligence Resources & Stock Charts

The APRI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APRI Detailed Price Forecast - CNN Money CNN View APRI Detailed Summary - Google Finance
Yahoo View APRI Detailed Summary - Yahoo! Finance Zacks View APRI Stock Research & Analysis -

Stock Analysis

TradeIdeas View APRI Trends & Analysis - Trade-Ideas Barrons View APRI Major Holders - Barrons
NASDAQ View APRI Call Transcripts - NASDAQ Seeking View APRI Breaking News & Analysis - Seeking Alpha
Spotlight View APRI Annual Report - OTC Report View APRI OTC Short Report -
TradeKing View APRI Fundamentals - TradeKing Charts View APRI SEC Filings - Bar Chart
WSJ View Historical Prices for APRI - The WSJ Morningstar View Performance/Total Return for APRI - Morningstar
MarketWatch View the Analyst Estimates for APRI - MarketWatch CNBC View the Earnings History for APRI - CNBC
StockMarketWatch View the APRI Earnings - StockMarketWatch MacroAxis View APRI Buy or Sell Recommendations - MacroAxis
Bullish View the APRI Bullish Patterns - American Bulls Short Pains View APRI Short Pain Metrics -

Social Media Mentions

StockTwits View APRI Stock Mentions - StockTwits PennyStocks View APRI Stock Mentions - PennyStockTweets
Twitter View APRI Stock Mentions - Twitter Invest Hub View APRI Investment Forum News - Investor Hub
Yahoo View APRI Stock Mentions - Yahoo! Message Board Seeking Alpha View APRI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for APRI - Insider Cow View Insider Transactions for APRI - Insider Cow
CNBC View APRI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APRI - OTC Markets
Yahoo View Insider Transactions for APRI - Yahoo! Finance NASDAQ View Institutional Holdings for APRI - NASDAQ

Stock Charts

FinViz View APRI Stock Insight & Charts - StockCharts View APRI Investment Charts -
BarChart View APRI Stock Overview & Charts - BarChart Trading View View APRI User Generated Charts - Trading View

Latest Financial News for APRI

Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date
Posted on Friday December 14, 2018

The Company announced that it needs additional time to solicit  stockholder votes in order to obtain affirmative votes from a majority of the voting power of the Company’s outstanding common stock, which is required for certain proposals at the meeting:  the reverse stock split (Proposal 2), which must be approved by a majority of the outstanding shares in order for the merger to close, and the name change to Seelos Therapeutics, Inc. (Proposal 3).  The Company announced that over 90% of the votes cast to date have been in favor of the merger with Seelos (Proposal 1) and over 80% of the votes cast to date have been in favor of each other proposal. The special meeting was adjourned until 8:00 a.m., Pacific Time, on January 4, 2019 at Latham & Watkins LLP, located at 12670 High Bluff Drive, San Diego, California 92130, its original location.

Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
Posted on Monday December 10, 2018

Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reminds shareholders to vote by proxy before the upcoming special stockholders meeting on December 14, 2018.  Apricus is holding a special meeting of stockholders in order to obtain the stockholder approvals required pursuant to the terms of the Merger Agreement with Seelos Therapeutics, Inc. and the Securities Purchase Agreement to finance the post-merger corporation or necessary under Nevada law, in order to complete the merger, the financing and related matters. The Apricus special meeting will be held at 8:00 a.m., Pacific time, on December 14, 2018 at Latham & Watkins LLP, located at 12670 High Bluff Drive, San Diego, California 92130, unless postponed or adjourned to a later date.  If you have questions or need help voting your shares, please call our proxy solicitation firm, Morrow Sodali LLC at 1-877-787-9239.

Report: Exploring Fundamental Drivers Behind Zedge, Apricus Biosciences, AquaBounty Technologies, Clarus, Dynasil Corporation of America, and The Rubicon Project — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Friday November 16, 2018

NEW YORK, Nov. 16, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

Apricus: 3Q Earnings Snapshot
Posted on Wednesday October 31, 2018

On a per-share basis, the San Diego-based company said it had a loss of 12 cents. In the final minutes of trading on Wednesday, the company's shares hit 35 cents. A year ago, they were trading at $1.67. ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.